Longboard Pharmaceuticals (NASDAQ:LBPH – Get Free Report)‘s stock had its “overweight” rating reissued by stock analysts at Cantor Fitzgerald in a research note issued to investors on Friday, Benzinga reports. They currently have a $60.00 price target on the stock. Cantor Fitzgerald’s price objective would indicate a potential upside of 178.68% from the stock’s current […]
Longboard Pharmaceuticals (NASDAQ:LBPH – Get Free Report)‘s stock had its “overweight” rating reissued by stock analysts at Cantor Fitzgerald in a research note issued to investors on Friday, Benzinga reports. They currently have a $60.00 price target on the stock. Cantor Fitzgerald’s price objective would indicate a potential upside of 178.68% from the stock’s current […]
HC Wainwright reaffirmed their buy rating on shares of Longboard Pharmaceuticals (NASDAQ:LBPH – Free Report) in a research report sent to investors on Tuesday morning, Benzinga reports. HC Wainwright currently has a $60.00 price objective on the stock. LBPH has been the topic of a number of other reports. Guggenheim increased their price objective on […]
Longboard Pharmaceuticals (NASDAQ:LBPH) Earns "Overweight" Rating from Cantor Fitzgerald theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Analysts Set Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) PT at $36.00 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.